{"id":"eurartesim-dispersible-oral-tablet","safety":{"commonSideEffects":[{"rate":"10%","effect":"headache"},{"rate":"8%","effect":"dizziness"},{"rate":"7%","effect":"nausea"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Dihydroartemisinin rapidly kills the asexual blood stages of Plasmodium falciparum by disrupting hemozoin formation and inducing oxidative stress, while piperaquine provides longer-lasting prophylactic activity against the parasite.","oneSentence":"Eurartesim is a fixed-dose combination of dihydroartemisinin and piperaquine, targeting the hemozoin formation in Plasmodium parasites to treat malaria.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:52:24.199Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Uncomplicated Plasmodium falciparum malaria"}]},"trialDetails":[{"nctId":"NCT01992900","phase":"PHASE2","title":"A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria","status":"COMPLETED","sponsor":"sigma-tau i.f.r. S.p.A.","startDate":"2013-11","conditions":"Malaria,Falciparum","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Piperaquine tetraphosphate plus dihydroartemisinin"],"phase":"phase_2","status":"active","brandName":"Eurartesim dispersible oral tablet","genericName":"Eurartesim dispersible oral tablet","companyName":"sigma-tau i.f.r. S.p.A.","companyId":"sigma-tau-i-f-r-s-p-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Eurartesim is a fixed-dose combination of dihydroartemisinin and piperaquine, targeting the hemozoin formation in Plasmodium parasites to treat malaria. Used for Uncomplicated Plasmodium falciparum malaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}